
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatGNTA ran from roughly $0.62 on May 20, 2026 to $1.80 now as traders chased its defense and aerospace pivot after the Sòphia High Tech deal and a fresh capital-raising setup into the June shareholder vote.
A failure to hold $1.50 could see a retrace toward $1.00 to $1.20. Any selling tied to Nasdaq bid-price pressure, dilution risk from the proposed capital authorization, or a weak read on the June 29, 2026 shareholder meeting would accelerate the downside.
If GNTA holds the $1.50 to $1.60 area on volume, a push back toward $2.25 to $2.75 is on the table. First resistance sits near $2.00, and any follow-through on the Sòphia HT closing or broader defense-sector momentum could keep dip buyers interested.
We don't currently have information about Genenta Science S.p.A.'s earnings.